真细菌
代谢物
2型糖尿病
生物化学
生物
新陈代谢
糖尿病
内分泌学
细菌
遗传学
作者
W D Li,L S Li,M J Lyu,Qiongying Hu,Daqian Xiong
出处
期刊:PubMed
日期:2023-01-06
卷期号:57 (1): 120-124
被引量:1
标识
DOI:10.3760/cma.j.cn112150-20220302-00195
摘要
Intestinal flora and its metabolites are closely related to the progression of type 2 diabetes mellitus(T2DM). Eubacterium is one of the dominant intestinal flora, and its metabolites short-chain fatty acids (SCFAs) play a leading role in regulating intestinal metabolic balance. It has been reported that SCFAs can regulate the secretion of glucagon-like peptide-1, improve the function of pancreatic β cells, participate in bile acids metabolism and regulate the production of inflammatory factors in T2DM. Based on the above research background, this article mainly reviews the relationship between Eubacterium and its metabolite SCFAs and T2DM and its regulatory mechanism.肠道菌群及代谢产物与2型糖尿病(type 2 diabetes mellitus,T2DM)的进展密切相关,优杆菌属是肠道菌群的主要优势菌群之一,其代谢物短链脂肪酸(short-chain fatty acids,SCFAs)在调节肠道代谢平衡中发挥主导作用。已有研究显示SCFAs具有调节T2DM中胰高血糖素样肽-1分泌、改善胰岛β细胞功能及参与胆汁酸代谢、调节炎性因子生成等作用。本文就优杆菌属及其代谢产物SCFAs与T2DM的关系及调控机制进行阐述。.
科研通智能强力驱动
Strongly Powered by AbleSci AI